Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study

INTRODUCTION: Approximately one third of all patients with cardiogenic shock suffer from acute kidney injury. Percutaneous coronary intervention, intra-aortic balloon pump, and continuous renal replacement therapy (CRRT) require effective antiplatelet therapy and anticoagulation, resulting in a high...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Link, Andreas, Girndt, Matthias, Selejan, Simina, Rbah, Ranja, Böhm, Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2008
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2575600/
https://ncbi.nlm.nih.gov/pubmed/18759963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc6998
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak